Publications
View AllEffect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
In patients with CKD and type 2 diabetes, treatment with finerenone resulted in lower risks of CKD progression and cardiovascular events than placebo. (Funded by Bayer; FIDELIO-...
Affiliated Researchers
Institution Info
- Type
- education
- Country
- ES
- Publications
- 3
- Citations
- 7,897
External Links
Identifiers
- ROR
- https://ror.org/04dp46240